The association between sunshine duration and paroxetine response time in patients with major depressive disorder

被引:0
|
作者
Tomita, T. [1 ]
Yasui-Furukori, N. [2 ]
Nakagami, T. [2 ]
Kaneda, A. [1 ]
Kaneko, S. [1 ]
机构
[1] Hirosaki Univ, Hirosaki, Aomori, Japan
[2] Hirosaki Univ, Odate City Gen Hosp, Hirosaki, Aomori, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-14-059
引用
收藏
页码:197 / 198
页数:2
相关论文
共 50 条
  • [1] The association between sunshine duration and paroxitine response time in patients with major depressive disorder
    Tomita, Tetsu
    Yasui-Furukori, Norio
    Nakagami, Taku
    Kaneda, Ayako
    Kaneko, Sunao
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 136 (03) : 1067 - 1071
  • [2] Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder
    Bozina, Nada
    Peles, Alma Mihaljevic
    Sagud, Marina
    Bilusic, Hrvoje
    Jakovljevic, Miro
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (03): : 190 - 197
  • [3] Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder
    Uchida, H
    Takeuchi, H
    Suzuki, T
    Nomura, K
    Watanabe, K
    Kashima, H
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (06) : 545 - 551
  • [4] Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder
    Chen, Chun-Yen
    Yeh, Yi-Wei
    Kuo, Shin-Chang
    Liang, Chih-Sung
    Ho, Pei-Shen
    Huang, Chang-Chih
    Yen, Che-Hung
    Shyu, Jia-Fwu
    Lu, Ru-Band
    Huang, San-Yuan
    PSYCHONEUROENDOCRINOLOGY, 2018, 87 : 108 - 118
  • [5] Plasma levels of interleukin-8 and response to paroxetine in patients with major depressive disorder
    Guan, Xuan
    Dong, Zai-Quan
    Hao, Yan-Ni
    Shen, Xiao-Ling
    Xie, Qing-Lian
    Chen, Jian-Min
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (06)
  • [6] Association of Neuroinflammation With Duration of Untreated Major Depressive Disorder
    Attwells, Sophia
    Setiawan, Elaine
    Wilson, Alan A.
    Mizrahi, Romina
    Rusjan, Pablo M.
    Miler, Laura
    Xu, Cynthia
    Sharma, Sarita
    Kish, Stephen
    Houle, Sylvain
    Meyer, Jeffrey
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S265 - S265
  • [7] Prediction of response to paroxetine treatment in patients with a depressive disorder
    Wittkampf, K. A.
    Ruhe, H. G.
    van Weert, H. C.
    Huyser, J.
    Bindels, P. E.
    Schene, A. H.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S87 - S87
  • [8] Longitudinal interplay between paroxetine response, cortisol and fatty acid metabolism in major depressive disorder
    Mocking, R. J. T.
    Verburg, H. F.
    Westerink, A. M.
    Assies, J.
    Vaz, F. M.
    Koeter, M. W. J.
    Ruhe, H. G.
    Schene, A. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S396 - S397
  • [9] Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation
    Takeuchi, Naohiro
    Nonen, Shinpei
    Kato, Masaki
    Wakeno, Masataka
    Takekita, Yoshiteru
    Kinoshita, Toshihiko
    Kugawa, Fumihiko
    NEUROPSYCHOBIOLOGY, 2017, 75 (02) : 81 - 88
  • [10] Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder
    Yoshimura, Reiji
    Kishi, Taro
    Hori, Hikaru
    Ikenouchi-Sugita, Atsuko
    Katsuki, Asuka
    Umene-Nakano, Wakako
    Iwata, Nakao
    Nakamura, Jun
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (02): : 355 - 357